tirzepatide for binge eating disorder Diagnostics and therapy disorders New hope for binge eating

A typical protocol looks like this: Weeks 1 through 4: 2 to 3mg daily

In December 2024, the FDA removed tirzepatide from its official drug shortage list

A new treatment strategy for Parkinsons disease through the gutbrain axis: the glucagon-like peptide-1 receptor pathway

All 50 patients 100% lost weight, with an average weight loss of 15.5% body weight or 43 pounds over the year

What experts say about peptides and long-term safety We dont know enough about injectable peptides to say what kinds of effects they may have on long-term health or safety

It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means that it acts like a hormone produced in the intestine that regulates insulin secretion and appetite